Public health effectiveness of the FDA 510(k) clearance process  balancing patient safety and innovation : workshop report /  [electronic resource] : 
 FDA 510(k) clearance process 
Theresa Wizemann, editor ; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. 
 - Washington, D.C. :  National Academies Press,  2010. 
 - xii, 128 p. :  col. ill. 
<br/><br/>Includes bibliographical references. 
<br/><br/><br/>Electronic reproduction. <br/>Palo Alto, Calif. : <br/>ebrary, <br/>2010. <br/>Available via World Wide Web. <br/>Access may be limited to ebrary affiliated libraries. 
<br/><br/><label>ISBN: </label>
<br/><br/><label>Subjects--Corporate Names: </label><br/>United States. Food and Drug Administration. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Public health--Standards--United States--Congresses.<br/>Public health--United States--Congresses.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Electronic books.
<br/><br/><label>LC Class. No.: </label>RA399.A3  / I57 2010eb